A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 15408
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ER
Long Form : estrogen receptor
No. Year Title Co-occurring Abbreviation
2021 Correlation between numerical and categorical immunohistochemical score of Ki-67 and HER2 with clinicopathological parameters of breast cancer. BC, HER2, PR
2020 4-Hexylphenol influences adipogenic differentiation and hepatic lipid accumulation invitro. 4-HP, EDC, OA, PPARgamma
2020 6'-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding. OI, RAL, RAL-A, SERM, WT
2020 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future. PR
2020 90 YEARS OF PROGESTERONE: Progesterone receptor signaling in the normal breast and its implications for cancer. BM, ECM, PR
2020 A 3D Heterotypic Breast Cancer Model Demonstrates a Role for Mesenchymal Stem Cells in Driving a Proliferative and Invasive Phenotype. BC, BCCs, EMT, MSAB, MSCs, PR, SnON, TGF-beta
2020 A Case of Carcinosarcoma of the Breast Presenting as Inflammatory Carcinoma and Review of the Literature. PR, SMA
2020 A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women. BC, NTUH, OR, PFAS, PFOS
2020 A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer. APTWI, DKI, HER2, Kapp, PR
10  2020 A deletion mutation within the ATBF1 gene is strongly associated with goat litter size. SWCG
11  2020 A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. ---
12  2020 A novel and cost-effective ex vivo orthotopic model for the study of human breast cancer in mouse mammary gland organ culture. BCa-MMOC, EGFR, MMOC, PR
13  2020 A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice. CIMBA, GPER
14  2020 A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressing HER2 expression in breast cancer. ERalpha, miRNAs, ZBTB1
15  2020 A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging. ABC, CBR, ORR, RECIST
16  2020 A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells. AhR, EDCs, PAH
17  2020 A population-based analysis of breast cancer incidence and survival by subtype in Ontario women. BCa, mOS, PgR, TNBC
18  2020 A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts. 4FMFES, HER2, p.i, ROI
19  2020 A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy. lncRNAs
20  2020 A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy. DRFS, NAC, pCR, RD, REO
21  2020 A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2- Primary Breast Cancer. PR
22  2020 A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer. PR, VOI
23  2020 A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. BC, EGFR, HER2, NLCs, PR, SLNs, TNBC, VEGF
24  2020 Abilities of beta-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. PDAC
25  2020 Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer. IHC, NAC, PR
26  2020 Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens. HER2, PR, VAB
27  2020 Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry. NFPAs, RT-dPCR
28  2020 Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. ---
29  2020 Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiol. BMI, CI, IDE, IIE, RR
30  2020 Adjuvant endocrine treatment for estrogen receptor (ER)-positive/HER2-negative breast cancer. CI, HR, OFS, RR, SOFT, TEXT
31  2020 Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer. BCS, HR, HT, NCDB, OS, RT
32  2020 Advances in the Molecular Taxonomy of Breast Cancer. HER2
33  2020 Advantages in Wound Healing Process in Female Mice Require Upregulation A2A-Mediated Angiogenesis under the Stimulation of 17beta-Estradiol. WT
34  2020 Age, Sex, and Depot-Specific Differences in Adipose-Tissue Estrogen Receptors in Individuals with Obesity. AT, OM
35  2020 AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner. AGR3, ESR1, si
36  2020 All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. CIs, CVD, HRs
37  2020 Allergy, asthma, and the risk of breast and prostate cancer: a Mendelian randomization study. CIs, ORs
38  2020 Alternaria toxins as casein kinase 2 inhibitors and possible consequences for estrogenicity: a hybrid in silico/in vitro study. ATX-II, CK2
39  2020 Amphiregulin mediates the hormonal regulation on Rspondin-1 expression in the mammary gland. AREG, Rspo1
40  2020 Amphiregulin retains ERalpha expression in acquired aromatase inhibitor resistant breast cancer cells. AIs, AREG, EGFR, FOXM1, SGK3
41  2020 AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. AMPK
42  2020 An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube. PgR
43  2020 An investigation of the relationship between TMPRSS6 gene expression, genetic variants and clinical findings in breast cancer. MCHC, TMPRSS6
44  2020 Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression. ---
45  2020 Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer. CNB, CR, HER2, PR
46  2020 Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model. AR, ARKO, DHT, PCOS
47  2020 Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells. CDK, CSC, HER
48  2020 Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo. MT
49  2020 APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status. A3A, A3B
50  2020 Aquaporin expression in breast cancer and their involvement in bleb formation, cell motility and invasion in endocrine resistant variant cells. AQPs, siRNA
51  2020 Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation. Arc
52  2020 ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. CRISPR
53  2020 ARID1A-dependent permissive chromatin accessibility licenses estrogen-receptor signaling to regulate circadian rhythms genes in endometrial cancer. ---
54  2020 Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report. USC
55  2020 Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study. AIs, EC, OS, PFS, PgR
56  2020 Assessing species-specific differences for nuclear receptor activation for environmental water extracts. AR, EDCs, GR, MR, PPARgamma, PR, PXR
57  2020 Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery. ALND, NAC
58  2020 Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures. AMH, AMHRII, IGFBP-1, PRL, RIF
59  2020 Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium. BCAC, OR, SNP
60  2020 Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. HDL-C, LDL-C, NAC, TC, TG
61  2020 Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. HR, LRR, PR
62  2020 Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer. BC, NAC, PET
63  2020 Association between low estrogen receptor positive breast cancer and staining performance. TMA
64  2020 Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers. AUC, CEA, PGRMC1, PR, ROC
65  2020 Association of genetic variants in Estrogen receptor (ESR)1 and ESR2 with susceptibility to recurrent pregnancy loss in Tunisian women: A case control study. BMI, ESR, ESR, MAF, RPL
66  2020 Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer. aHR, OS, RFS
67  2020 Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients. HR
68  2020 Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence. BIA-ALCL, DFS, HRs, LRRFS
69  2020 Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database. HR, OS, PR, TPBC
70  2020 Basal-like Breast Cancer: Comparison of Imaging Characteristics. HER2, ICMF, PR
71  2020 Benzo[a]pyrene exposure induced reproductive endocrine-disrupting effects via the steroidogenic pathway and estrogen signaling pathway in female scallop Chlamys farreri. ADCY, Cav-1, PKA, VTG
72  2020 Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer. AI, AR, CBR, ORR, PFS
73  2020 BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer. BIK
74  2020 Binding Assays Using a Benzofurazan-Labeled Fluorescent Probe for Estrogen Receptor-Ligand Interactions. hr-ERalpha
75  2020 Binding specificities of estrogen receptor with perfluorinated compounds: A cross species comparison. PFCs
76  2020 Bioassay guided analysis coupled with non-target chemical screening in polyethylene plastic shopping bag fragments after exposure to simulated gastric juice of Fish. NTS
77  2020 Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer. CBX, NPI, PR, SBR
78  2020 Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer. BC, pam, PAM, SAM
79  2020 Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer. bc-GenExMiner, DFS, DMFS, HER2, LRRC15, OS, PR, RFS, SBR
80  2020 Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer. NOD2, NPI, PR, SBR
81  2020 Biological effects of chronic and acute exposure of human endothelial cell line EA.hy926 to bisphenol A: New tricks from an old dog. BPA, EC, eNOS, NO, ZO-1
82  2020 Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases. ALN, ASCO, BC, CAP, HER2, PR
83  2020 Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study. IGF-1, IGFBP-1
84  2020 Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002. ALND, PgR, SLNB
85  2020 Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer. ---
86  2020 Biomimetic and estrogenic fibers promote tissue repair in mice and human skin via estrogen receptor beta. HA, SPI
87  2020 Bispecific Antibodies for Triple Negative Breast Cancer. HER2, TNBC
88  2020 Bisphenol a Exposure in Utero Disrupts Hypothalamic Gene Expression Particularly Genes Suspected in Autism Spectrum Disorders and Neuron and Hormone Signaling. BNST, BPA, DEGs, MPOA
89  2020 Bisphenol A-induced oxidative stress, hepatotoxicity and altered estrogen receptor expression in Labeo bata: impact on metabolic homeostasis and inflammatory response. BPA, NO, VTG
90  2020 Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study. CI, OR
91  2020 Blocking of Estradiol Receptors ERalpha, ERbeta and GPER During Development, Differentially Alters Energy Metabolism in Male and Female Rats. ---
92  2020 BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivors. AA, BC, EA, PA, SI
93  2020 Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women. CI, DFI, HR, RFD
94  2020 BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction. HR
95  2020 BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy. BC, TNBC
96  2020 BRCA Mutational Status is a Promising Predictive Biomarker for Platinum-based Chemotherapy in Triple-Negative Breast Cancer. BRCA, HER2, HRR, PARPi, Rp, TNBC
97  2020 Breast cancer in Andaman and Nicobar Islands: A retrospective analysis. PR
98  2020 Breast Cancer in Men: A Single Center Experience Over a Period of 22 years. MBC, PR
99  2020 Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model. PR
100  2020 Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFkappabeta interplay. Nrf2